Clinical and Experimental Medicine

Papers
(The TQCC of Clinical and Experimental Medicine is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Sjögren’s syndrome: a systemic autoimmune disease157
Anemia in patients with Covid-19: pathogenesis and clinical significance78
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options69
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis48
Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis46
Kidney disease and COVID-19 disease severity—systematic review and meta-analysis44
A review of prognostic and predictive biomarkers in breast cancer36
Zinc as a complementary treatment for cancer patients: a systematic review34
COVID-19: time to flatten the infodemic curve25
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart23
The use of ketogenic diets in cancer patients: a systematic review22
Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer20
Immune-inflammatory, coagulation, adhesion, and imaging biomarkers combined in machine learning models improve the prediction of death 1 year after ischemic stroke18
A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis18
Stem cells therapy in acute myocardial infarction: a new era?18
The NEK family of serine/threonine kinases as a biomarker for cancer17
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis12
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance12
Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus12
REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma11
0.022449970245361